Evidence map›Paper›PMID 35970992›Full record

ArticleNature communications2022

Sirt2 promotes white matter oligodendrogenesis during development and in models of neonatal hypoxia.

Beata Jablonska, Katrina L Adams, Panagiotis Kratimenos, Zhen Li, Emma Strickland, Tarik F Haydar, Katharina Kusch, Klaus-Armin Nave, Vittorio Gallo

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. A canineProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Beata Jablonska *Center for Neuroscience Research, Children's National Research Institute, Children's National Hospital, Washington, DC, 20010, USA. bjablonska@childrensnational.org.
Katrina L Adams *Center for Neuroscience Research, Children's National Research Institute, Children's National Hospital, Washington, DC, 20010, USA.ORCID 0000-0001-5290-4245
Panagiotis KratimenosCenter for Neuroscience Research, Children's National Research Institute, Children's National Hospital, Washington, DC, 20010, USA.
Zhen LiCenter for Neuroscience Research, Children's National Research Institute, Children's National Hospital, Washington, DC, 20010, USA.
Emma StricklandCenter for Neuroscience Research, Children's National Research Institute, Children's National Hospital, Washington, DC, 20010, USA.
Tarik F HaydarCenter for Neuroscience Research, Children's National Research Institute, Children's National Hospital, Washington, DC, 20010, USA.
Katharina KuschMax Planck Institute of Experimental Medicine, Department of Neurogenetics, Gottingen, Germany.ORCID 0000-0002-5079-502X
Klaus-Armin NaveMax Planck Institute of Experimental Medicine, Department of Neurogenetics, Gottingen, Germany.ORCID 0000-0001-8724-9666
Vittorio GalloCenter for Neuroscience Research, Children's National Research Institute, Children's National Hospital, Washington, DC, 20010, USA. vgallo@childrensnational.org.ORCID 0000-0002-2429-0845
Children's National · USMax Planck Institute of Experimental Medicine · DE

Funding

Neurobehavioral Evaluation CoreP50HD105328 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI WILLIAM Davis GAILLARD · 2021 to 2026
$9.3M
Research_ProjectU54HD090257 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI VITTORIO GALLO, VITTORIO GALLO VITTORIO GALLO · 2016 to 2020
$5.9M
Mechanisms of White Matter Development in Down SyndromeR01NS105138 · NINDS · CHILDREN'S RESEARCH INSTITUTE · PI HAYDAR, TARIK F, VITTORIO GALLO, VITTORIO GALLO VITTORIO GALLO · 2018 to 2022
$3.8M
Mechanisms of Oligodendrocyte and Axonal Abnormalities After Perinatal Brain InjuryR37NS109478 · NINDS · SEATTLE CHILDREN'S HOSPITAL · PI GALLO, VITTORIO · 2018 to 2025
$3.1M
NICHD NIH HHS P50 HD105328NICHD NIH HHS U54 HD090257NINDS NIH HHS R01 NS105138NINDS NIH HHS R37 NS109478
6 · The paper itself

Abstract

Delayed oligodendrocyte (OL) maturation caused by hypoxia (Hx)-induced neonatal brain injury results in hypomyelination and leads to neurological disabilities. Previously, we characterized Sirt1 as a crucial regulator of OL progenitor cell (OPC) proliferation in response to Hx. We now identify Sirt2 as a critical promoter of OL differentiation during both normal white matter development and in a mouse model of Hx. Importantly, we find that Hx reduces Sirt2 expression in mature OLs and that Sirt2 overexpression in OPCs restores mature OL populations. Reduced numbers of Sirt2

Indexed as

HypoxiaOligodendrogliaSirtuin 2White MatterAnimalsCell DifferentiationHumansInfantInfant, NewbornMiceSirtuin 1SIRT2 protein, humanSirtuin 1Sirtuin 2

Identifiers

PMID35970992
PMCPMC9378658
OpenAlexW4291511546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.